Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Bindu Shajan Perappadan

Process underway to ensure commercial availability of Lumpy Skin disease vaccine

The process is now underway to ensure the commercial availability of India’s indigenous vaccine Lumpi-ProVac to protect livestock from Lumpy Skin disease, confirmed Dr. Yash Pal, Director, National Research Centre on Equines, on Tuesday, speaking to The Hindu.

He also cautioned against the use of raw milk, especially during this infection phase, explaining that while pasteurized and boiled milk is safe, raw milk carries high levels of disease-causing bacteria.

Lumpi-ProVac has been developed by the National Research Centre on Equines, Hisar (Haryana) in collaboration with the Indian Veterinary Research Institute, Izatnagar (Bareilly). The vaccine was launched earlier this month by Union Minister for Agriculture and Farmers Welfare, Narendra Singh Tomar. “Ever since the disease came to India in 2019, research institutes have been engaged in developing the vaccine,” the Minister had said.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.